Philippine Legislators Introduce Bill To Add Drug Pricing Board
This article was originally published in PharmAsia News
Philippine lawmakers are moving to create a government agency to cap the prices on all types of drugs sold in the country. Three representatives said their proposed measure would create the Drug Price Regulatory Board as part of an effort to lower drug prices beyond the impact of the recently created Cheaper Medicines Law. They said caps required by the new law were delayed by large pharmaceutical firms in collusion with the administration. Widespread price caps had been attempted in creation of the Cheaper Medicines Law, but the effort was not successful. (Click here for more
You may also be interested in...
Avadim Health argues National Advertising Division expects substantiation for its homeopathic topical claims at the same level FDA requires for NDAs. NAD also said although FTC’s competent, reliable scientific evidence standard is “flexible” to some degree, pain claims are held to a more rigid standard.
With Roche's oral spinal muscular atrophy therapy Evrysdi off to a strong start after its recent US launch, Novartis is switching its priorities for rival RNA-splicing drug branaplam and putting it into a Phase IIb trial for Huntington's disease.
The FDA has asked the company for more information to support its PoNS therapy for multiple sclerosis patients with gait deficit, including an additional analysis of clinical data and labeling modifications.